0
0
0
s2smodern

As a primary care physician, I will be watching closely on Jan. 24 when the Food and Drug Administration’s Tobacco Products Scientific Advisory Committee (TPSAC) meets to review the Modified Risk Tobacco Product Application of Philip Morris International IQOS product. The agency recently announced it will convene a public hearing to examine the merits of a new heat-not-burn tobacco technology [...]